Tenet Healthcare (THC) Tops Q4 EPS by 49c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Tenet Healthcare (THC) PT Lowered to $185 at Raymond James, 'Selloff After Quarter is Perplexing — Creates Attractive Entry Point Despite Policy Risks'
February 13, 2025 8:45 AM ESTRaymond James analyst John Ransom lowered the price target on Tenet Healthcare (NYSE: THC) to $185.00 (from $195.00) while maintaining a Outperform rating.
The analyst comments "We reiterate our Outperform rating on shares of THC while lowering our price target to $185 (8.5x 2026 EBITDA ex-NCI) following 4Q24 results that were slightly... More
